SYGNIS to Present at the 11th Rodman & Renshaw Annual Global Investment Conference

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service125 times read : Adjust font size: Decrease font Enlarge font
image

HEIDELBERG, Germany - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) announced today that the company will present at the 11th Rodman & Renshaw Annual Global Investment Conference, September 9-11, 2009 at the New York Palace Hotel, New York. The presentation will be given by Prof. Karoly Nikolich, CEO of the SYGNIS subsidiary Amnestix [...]

Read this article...



Post your comment comment Comments (0 posted)

copyright